Intuitive Surgical, Inc.

NASDAQ Global Select
Back to all articles
Bullish +55

Insider Selling: Intuitive Surgical (NASDAQ:ISRG) EVP Sells $30,081.59 ...

AI-generated analysis

📉 ISRG EVP Mark Brosius sold 77 shares for $30,081.59 under a pre-arranged Rule 10b5-1 trading plan on August 17th.

💰 The company reported Q2 EPS of $2.80, beating the consensus estimate of $2.48 by $0.32.

📈 ISRG revenue reached $2.89 billion for the quarter, exceeding analyst expectations of $2.83 billion.

🚀 Revenue grew 18.4% year-over-year, demonstrating continued strong demand for robotic surgical systems.

🏦 Norges Bank acquired a new stake worth approximately $2.86 billion in the fourth quarter.

📊 Institutional ownership stands at 83.64%, with significant additions from J. Stern & Co. and Northwestern Mutual.

🎯 Analyst consensus rating is 'Moderate Buy' with a target price of $508.68 according to MarketBeat.

📉 Bank of America lowered its price target from $520 to $515 in a recent research report.

📈 Sanford C. Bernstein reaffirmed an 'outperform' rating on ISRG shares in August.

💻 The company maintains a market cap of $140.51 billion with a PE ratio of 45.56.

Bullish Signals
  • Intuitive Surgical beat Q2 earnings estimates with EPS of $2.80 versus the consensus of $2.48.
  • The company reported revenue of $2.89 billion, surpassing analyst expectations of $2.83 billion.
  • Revenue increased 18.4% year-over-year, highlighting strong growth in its robotic surgical systems business.
  • Norges Bank added a new stake worth $2.86 billion to its holdings in the fourth quarter.
  • J. Stern & Co. LLP grew its stake by 18,504.6% in the fourth quarter, adding over 2 million shares.
  • Arrowstreet Capital Limited Partnership lifted its stake by 95.3% in the first quarter.
  • Sanford C. Bernstein reaffirmed an 'outperform' rating on ISRG shares in a recent research note.
  • Oppenheimer upgraded its rating to 'outperform' and set a $500 price objective for the stock.
Risk Factors
  • Bank of America dropped its price target from $520.00 to $515.00 in a research report.
  • Mizuho assigned a 'neutral' rating and set a $500.00 price target on ISRG shares.
  • Citigroup reduced its price target from $590.00 to $500.00, though it maintained a 'buy' rating.
  • The stock trades at a high PE ratio of 45.56, which may limit upside potential if growth slows.
Full Analysis
Intuitive Surgical (ISRG) EVP Mark Brosius sold 77 shares of the company's stock on August 17th for a total value of $30,081.59 at an average price of $390.67 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan and resulted in a 6.08% decrease in his direct ownership, leaving him with 1,189 shares valued at approximately $464,506. This insider sale is a routine disclosure filed with the SEC. The company recently reported strong quarterly financial performance, beating analyst expectations for both earnings per share and revenue. Intuitive Surgical posted EPS of $2.80 compared to a consensus of $2.48, while revenue reached $2.89 billion against expectations of $2.83 billion. Year-over-year revenue growth was 18.4%, driven by the company's core robotic-assisted surgical systems and related technologies. Institutional investors have significantly increased their stakes in Intuitive Surgical over the past few quarters, with major entities like Norges Bank, Bank of New York Mellon, and J. Stern & Co. adding substantial positions. Hedge funds and wealth management firms collectively hold a large portion of the float, indicating strong institutional confidence despite mixed analyst price targets ranging from $500 to $590.